Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685631 · ClinicalTrials.gov registry record
Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- 1,653
- Enrollment target
NCT02685631 is a clinical trial that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 1,653 participants.
The verdict
NCT02685631 has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- 1,653 participants
- Enrollment target
Study Summary
This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.
Interventions
- OTHER Yttrium-90 Resin Microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,653 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02685631
The ClinicalTrials.gov registry entry for NCT02685631 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yttrium-90 Resin Microspheres is the first listed.
NCT02685631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02685631 about?
NCT02685631 is a clinical study titled "Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study". This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The i...
What is the current status of trial NCT02685631?
This trial is currently completed. The enrollment target is 1,653 participants. The study started on 2015-07. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT02685631?
The interventions under investigation include: Yttrium-90 Resin Microspheres (OTHER).
Who is sponsoring clinical trial NCT02685631?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.